Chief Operating Officer
CurrentAt VarmX, we're transforming the treatment of inherited and acquired coagulation factor disorders that cause bleeding or thrombosis. As COO at VarmX, I’m harnessing my 25+ years of expertise in clinical development, strategy, commercialization, and global business development to bring VarmX to the next growth phase. We're gearing up for a Series C funding.